CN Patent

CN118546091B — 一种5-乙酰基-1h-吡唑-3-羧酸及其制备方法和应用

Assigned to Jinan Carbotang Biotech Co ltd · Expires 2026-04-10 · 0y expired

What this patent protects

本发明属于有机合成的技术领域,具体的涉及一种5‑乙酰基‑1H‑吡唑‑3‑羧酸及其制备方法和应用。所述制备方法首先利用原料3,5‑吡唑二甲酸和叔丁醇反应得到中间体a;然后将中间体a与N,O‑二甲基羟胺盐酸盐反应得到中间体b;再将中间体b和甲基溴化镁反应得到中间体c,最后,采用碱液水解中间体c,并用酸中和得到5‑乙酰基‑1H‑吡唑‑3‑羧酸。反应采用的原料易得,反应的条件温和,操作简单,且产品的总收率>70%,产品纯度达到99.9%以上,适合大规模的工业化生产。

USPTO Abstract

本发明属于有机合成的技术领域,具体的涉及一种5‑乙酰基‑1H‑吡唑‑3‑羧酸及其制备方法和应用。所述制备方法首先利用原料3,5‑吡唑二甲酸和叔丁醇反应得到中间体a;然后将中间体a与N,O‑二甲基羟胺盐酸盐反应得到中间体b;再将中间体b和甲基溴化镁反应得到中间体c,最后,采用碱液水解中间体c,并用酸中和得到5‑乙酰基‑1H‑吡唑‑3‑羧酸。反应采用的原料易得,反应的条件温和,操作简单,且产品的总收率>70%,产品纯度达到99.9%以上,适合大规模的工业化生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN118546091B
Jurisdiction
CN
Classification
Expires
2026-04-10
Drug substance claim
No
Drug product claim
No
Assignee
Jinan Carbotang Biotech Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.